Drug Abuse Aspects of HIV/AIDS (R01)

The summary for the Drug Abuse Aspects of HIV/AIDS (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Drug Abuse Aspects of HIV/AIDS (R01): -Purpose. The purpose of this Funding Opportunity Announcement (FOA) from the National Institute on Drug Abuse is to encourage drug abuse research to address the changing dynamics of the HIV/AIDS epidemic in the U.S., such as the increasing over-representation of minorities and women among new AIDS cases and role of heterosexual sex as a transmission route. Studies are needed to develop novel preventive interventions that more effectively address the evolving epidemic. Internationally, studies are needed on how to translate and adapt interventions that have proved effective in the U.S. to other communities and international settings and to learn from other conditions and cultures to inform our understanding of the causes, consequences, and differences in HIV-associated risks, morbidity, and mortality in diverse populations. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-308 that solicits applications under the R03 mechanism and PA-07-309 that solicits applications under the R21 mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Drug Abuse Aspects of HIV/AIDS (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-307
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jan 17, 2007
Creation Date: Jan 17, 2007
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments Private institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) County governments Independent school districts City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiolog...
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Op...
Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use ...
Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rh...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Bridges to the Doctorate Research Training Program (T32)
Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional)
NIDCR Mentored Career Development Award to Promote Broad Participation in Research (K01 In...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com